Pure FECO Oil in Syringes (60 x 1ml)
n 2026, the graduated syringe (often 1ml or 3ml) remains the standard delivery vehicle for a high-intensity cancer protocol. While capsules offer convenience, syringes provide a level of clinical flexibility that is necessary for the titration phases of advanced oncological care.
1. Ultra-Precise Titration (The "Micro-Adjust")
The hallmark of a 2026 cancer protocol is the ability to slowly build tolerance to massive doses of THC.
Fractional Dosing: Unlike a fixed 100mg capsule, a syringe allows a patient to increase their dose by increments as small as 0.01ml (approx. 5–10mg). This is critical during the first 3 weeks of a protocol to avoid overwhelming psychoactivity or "greening out."
Visual Confirmation: Graduated markings on the side of the syringe provide the patient or caregiver with immediate visual proof of the exact volume being consumed, which is vital for maintaining the strict "90-day regimen" timeline.
2. Multi-Modal Administration (Sublingual vs. Oral)
Syringes allow the patient to choose the route of administration based on their immediate needs:
Sublingual (Immediate Relief): By placing the oil directly under the tongue, the cannabinoids bypass the digestive system and enter the bloodstream via the sublingual vein. This is the preferred method for "breakthrough" nausea or sudden pain spikes, as effects are felt within 15–30 minutes.
Oral (Long-Term Stability): When the oil is swallowed (often on a piece of fruit or cracker), it is processed by the liver into 11-Hydroxy-THC. This creates a "time-release" effect that is ideal for overnight pain management and suppressing chronic inflammation.
3. Versatility for "Refractory" Patients
For patients in advanced stages of cancer who may struggle with swallowing or severe nausea, the syringe is the only viable option:
Topical Application: FECO from a syringe can be applied directly to skin lesions (such as in basal cell carcinoma protocols) or mixed with a carrier oil for localized relief.
Suppository Compounding: Many 2026 protocols recommend using the syringe to dispense FECO into cocoa butter molds. Rectal administration allows for massive doses (500mg+) with significantly reduced psychoactive effects, as it bypasses the "first-pass" metabolism of the liver.
Feeding Tube Compatibility: For patients with esophageal or throat cancers, FECO from a syringe can be easily integrated into a G-tube or J-tube feeding regimen.
Syringe vs. Capsule for Cancer Care (2026)
| Feature | FECO Syringe (Concentrate) | FECO Capsules (Fixed Dose) |
|---|---|---|
| Best For | Titration & Rapid Relief. | Maintenance & Convenience. |
| Absorption Speed | Fast (if taken sublingually). | Slow (requires 90+ mins for digestion). |
| Dose Control | Variable (0.01ml to 1.0ml). | Fixed (e.g., 25mg, 50mg, 100mg). |
| Storage | Requires careful capping; high viscosity. | Stable; easy to transport. |
4. 2026 "Syringe Hygiene" and Safety
Warm Water Bath: High-quality FECO is thick and "tar-like." In 2026, patients are advised to place the capped syringe in a bowl of warm water for 60 seconds to make the oil flowable, preventing "plunger snap" (where the oil suddenly shoots out too fast).
Back-Pull Technique: To prevent waste, patients are taught to pull the plunger back slightly after dispensing to "suck" the remaining oil out of the tip and into the barrel.
Oxidation Shielding: Always keep the cap tightly secured. Exposure to air can convert the THC into CBN, which may make the protocol too sedative for daytime use.
